Comparison of sodium-glucose cotransporter-2 (SGLT2) inhibitors to reduce cardiovascular and renal outcomes: a network meta-analysis of randomized controlled trials

被引：0
|
作者：
Kani, R. [1 ]
Watanabe, A. [2 ]
Miyamoto, Y. [3 ]
Kuno, T. [4 ]
机构：
[1] Kameda Med Ctr, Kamogawa, Japan
[2] Univ Tsukuba, Div Hosp Med, Ibaraki, Japan
[3] Ctr Dis Control & Prevent, Div Diabet Translat, Surveillance Econ & Stat Branch, Atlanta, GA USA
[4] Albert Einstein Coll Med, Div Cardiol, Montefiore Med Ctr, New York, NY USA
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Sodium-Glucose Cotransporter-2 Inhibitors and Primary Prevention of Atherosclerotic Cardiovascular Disease: A Meta-Analysis of Randomized Trials and Systematic Review
    Rahman, Hammad
    Khan, Safi U. U.
    Lone, Ahmad N. N.
    Ghosh, Priyanka
    Kunduru, Mahathi
    Sharma, Saurabh
    Sattur, Sudhakar
    Kaluski, Edo
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (16):
  • [32] Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors for Cardiovascular Disease Prevention
    Reid, Jessica
    Rana, Khyatiben
    Niman, Stephanie
    Sheikh-Ali, Mae
    Lewis, Todd
    Choksi, Rushab R.
    Goldfaden, Rebecca F.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (05) : 419 - 429
  • [33] Role of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors
    Lusk, Kathleen A.
    Barnes, Nicole E.
    US PHARMACIST, 2016, 41 (11) : 38 - 42
  • [34] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Stroke
    Kimura, Genjiro
    CIRCULATION JOURNAL, 2017, 81 (06) : 898 - 898
  • [35] Evaluating the overall renal outcomes of sodium-glucose cotransporter-2 (SGLT2) inhibitors in patients with chronic kidney disease (CKD)
    Cao, Min-Jia
    Liang, Ting-Ting
    Xu, Li
    Shi, Fang-Hong
    DIABETOLOGY & METABOLIC SYNDROME, 2025, 17 (01):
  • [36] Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors for Cardiovascular Disease Prevention
    Jessica Reid
    Khyatiben Rana
    Stephanie Niman
    Mae Sheikh-Ali
    Todd Lewis
    Rushab R. Choksi
    Rebecca F. Goldfaden
    American Journal of Cardiovascular Drugs, 2020, 20 : 419 - 429
  • [37] Sodium-Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Lin, Norman H. Y.
    Ho, Jamie S. Y.
    Leow, Aloysius S. T.
    Teo, Yao Hao
    Yeo, Brian S. Y.
    Zhang, Audrey A. Y.
    Goh, Fang Qin
    Yeo, Tiong-Cheng
    Wong, Raymond C. C.
    Chai, Ping
    Chan, Mark Y. Y.
    Sia, Ching-Hui
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2025, 25 (01) : 71 - 81
  • [38] Sodium-glucose cotransporter-2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis
    Mascolo, Annamaria
    Rafaniello, Concetta
    di Mauro, Gabriella
    Ruggiero, Donatella
    Campitiello, Maria Rosaria
    Donniacuo, Maria
    Berrino, Pasquale Maria
    Rossi, Francesco
    Paolisso, Giuseppe
    Capuano, Annalisa
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [39] The Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors on Cardiovascular Outcomes and All-Cause Mortality in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
    Sinha, Tanya
    Khilji, Faria
    Laraib, Fnu
    Fatima, Farhana
    Kaur, Mandeep
    Chaudhari, Sandipkumar S.
    Agbor, Divine Besong Arrey
    Khan, Areeba
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [40] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
    Kalra S.
    Cardiology and Therapy, 2016, 5 (2) : 161 - 168
12345